Đang chuẩn bị liên kết để tải về tài liệu:
Beta-blocker use and COPD mortality: A systematic review and meta-analysis
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Despite the benefits of beta-blockers in patients with established or sub-clinical coronary artery disease, their use in patients with chronic obstructive pulmonary disease (COPD) has been controversial. Currently, no systematic review has examined the impact of beta-blockers on mortality in COPD. |